<DOC>
	<DOCNO>NCT00111488</DOCNO>
	<brief_summary>The purpose Randomized Study Surgical Ablation Microwave Energy Treatment Atrial Fibrillation ( RESOLVE-AF ) trial determine safety effectiveness Guidant FLEXÂ® Microwave Surgical Ablation System treatment permanent atrial fibrillation ( AF ) .</brief_summary>
	<brief_title>Guidant Microwave Ablation System Treatment Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Patient age &gt; = 18 year Documented permanent AF ( least three month ) Scheduled open chest cardiac surgery primary indication mitral valve repair replacement Has inform nature study , agree provision , provide write informed consent , approve appropriate Institutional Review Board/Ethics Committee respective clinical site Cerebral vascular accident ( CVA , stroke ) transient ischemic attack ( TIA ) within previous 6 month Myocardial infarction within previous 6 week Documented history pulmonary vein stenosis Previous ablation attempt AF Previous thoracic procedure Left atrial size &gt; 7.0 cm Left ventricular ejection fraction &lt; 30 % Presence leave atrial left atrial appendage thrombus Esophageal fistula stricture , untreated esophagitis , varix , dysphagia odynophagia contraindicate transesophageal echocardiography Known allergy contraindication warfarin therapy Known allergy contraindication antiarrhythmic ( Classes IA , IC , III ) therapy Other comorbidity reduce life expectancy le 1 year protocol noncompliance would limit followup Geographically remote unable return followup examination Pregnant plan become pregnant study Enrolled concurrent study , without Guidant write approval , may confound result study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>atrial fibrillation</keyword>
</DOC>